--:--:--

NGL Fine-Chem Limited

Web: nglfinechem.com NSE: NGLFINE BSE: 524774 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

2838 106(4%)

Volume

27k as on 23, Jun

Open

1,962

High

1,988

Low

1,899

Close

2,732

VWAP

3,112

52 Week High

3,602

52 Week Low

1,271

Viand Research Rating
Quality Score

66/100

Growth Score

90/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy
Analyst Price Target
-
Market Cap (cr)

1,753

No. of Shares

0.62

P/E

29.85

P/B

4.27

Face Value

5

Div. Yield

-

Book Value (TTM)

-

CASH

-

DEBT

-

EPS (TTM)

-

ROE

14.31

ROCE

-

Profit Growth

-

Listing Date

08-Jul-22

Rank/Sector Rank

#1272/-

Promoter Holding

72.49%

FII Holding

0.05%

DII Holding

0.02%

Price Chart
Price Performance
1 Week3%
1 Month12%
3 Months50%
6 Months30%
1 Year30%
YTD30%
Moving Average
5 Day SMA3,050
10 Day SMA2,991
20 Day SMA2,853
30 Day SMA2,702
50 Day SMA2,550
61 Day SMA2,483
80 Day SMA0
200 Day SMA0
PIVOT LEVEL
StandardCamarillaFibonacciWoodie's
Resistance 33,3613,1903,2763,403
Resistance 23,2763,1773,2193,297
Resistance 13,2133,1633,1843,254
Pivot Point3,1273,1493,1273,148
Support 13,0643,1363,0703,106
Support 22,9783,1223,0352,999
Support 32,9153,1082,9782,957
Competitors/Peers
#SymbolMCAPLTP1W1M6M1YP/EInd PEDebt/EqNP Qtr Rs.Cr.
1SUNPHARMA4,43,00318641%3%4%13%3757.70.0711509
2DIVISLAB2,48,26693522%9%53%55%6957.702568
3TORNTPHARM1,87,70749352%1%16%35%7257.71.792138
4APOLLOHOSP1,27,04190201%2%20%15%5857.70.92003
5ZYDUSLIFE1,15,94011626%4%31%11%2057.70.313560
6CIPLA1,11,81613782%3%10%9%2257.70.023862
7LAURUSLABS1,08,41420064%11%103%120%057.70.48890
8MAXHEALTH1,02,83010663%6%10%9%057.70.321442
9MANKIND1,02,43524809%4%24%3%4957.70.391938
10DRREDDY1,01,07712162%1%8%10%2057.70.24158
Load More
Shareholding Pattern (%)
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021
Promoters(-0.21) 72.49%(0.01) 72.73%(0.01) 72.74%(0.01) 72.74%(0.01) 72.74%(0.01) 72.74%(0.01) 72.74%(0.01) 72.74%(0.01) 72.74%(-0.31) 72.74%(0.01) 73.06%(-0.51) 73.06%(0.01) 73.53%(-0.31) 73.53%(0.01) 73.81%(0.01) 73.81%(0.01) 73.81%(0.01) 73.81%(0.01) 73.81%(0.01) 73.81%
FIIs(0.01) 0.05%(0.01) 0.03%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(-0.11) 0.00%(0.01) 0.05%(0.01) 0.02%(-0.11) 0.03%(0.11) 0.10%(0.01) 0.04%(0.01) 0.02%(0.01) 0.00%(0.01) 0.00%(-0.11) 0.00%(0.01) 0.05%(0.01) 0.05%(0.01) 0.01%(0.01) 0.00%(0.01) 0.00%
DIIs(0.01) 0.02%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.01%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%(0.01) 0.00%
Public27.43%27.23%27.26%27.26%27.26%27.26%27.23%27.25%27.24%27.16%26.91%26.93%26.46%26.47%26.19%26.13%26.14%26.18%26.19%26.19%
No. of Shareholders13,39312,51612,83413,38714,01014,38614,11014,57514,60815,04116,41017,62317,06618,28718,44018,50418,04217,06815,69510,832
Quarterly Results
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021
Sales13914912812010495899391100888071757267.7265.2584.0681.1478.3775.86
Sales Growth % (YoY)33.6%57.1%43.1%28.6%14.8%-4.8%1.3%16.6%27.7%32.8%22.3%18.4%8.9%-11%-11.4%-13.6%-14%17.1%11.6%14.7%79.3%
Sales Growth % (QoQ)-6.7%16.4%6.7%15.4%9.5%6.7%-4.3%2.2%-9%13.6%10%12.7%-5.3%4.2%6.3%3.8%-22.4%3.6%3.5%3.3%-
Expenses116128105103938984828184746661616258.5763.173.568.6461.2152.29
Operating Profit2321221711651291614141014109.152.1510.5612.517.1623.57
OPM %171418141176121016161714191413.513.312.5615.4121.931.07
Other Income72526-10564433110.472.52.983.844.394.55
Interest1111111000000000.120.51.540.420.40.37
Depreciation5555433333333313.253.63.482.422.22.18
Profit before tax2418211312111312161414101296.250.558.5213.518.9525.57
Tax %252424262249-1262223302516232825.445.4519.626.326.6525.22
Net Profit 181316109111091210109964.670.526.879.9513.9119.13
Net Profit Growth % (QoQ)38.5%-18.8%60%11.1%800%--90%11.1%-25%20%-11.1%-50%28.5%798.1%-92.4%-31%-28.5%-27.3%-
Net Profit Growth % (YoY)100%1200%1500%---91.7%-90%--33.3%66.7%114.1%1630.8%31%-39.7%-66.4%-97.3%----
TTM Net Profit57483621212132414141383428.6720.1918.0622.0131.2549.8642.9933.040
EPS in Rs29.7821.8425.415.5914.960.872.0715.8814.9219.9416.2416.9613.7715.0910.517.560.8411.1216.1122.5230.96
Profit and Loss
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Sales501368339278318258152153
Sales Growth %36%8.7%21.8%-12.4%23.1%70.1%-1%-
Expenses421333285243249178130121
Operating Profit8035543568802232
OPM %1610161321311421
Other Income8814611814
Interest53222233
Depreciation2012121110886
Profit before tax6328542767781228
Tax %2424242525273127
Net Profit 482141205057820
Net Profit Growth %128.6%-48.8%105%-60%-12.3%612.5%-60%-
EPS in Rs77.9134.1966.8833.1880.7791.8113.532.58
Dividend Payout %253522135
Cash Flows
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Cash from Operating Activity433220351427209
Cash from Investing Activity-71-70-27-27-14-25-20-10
Cash from Financing Activity3037-1-1-1-1-10
Net Cash Flow20-77-120-1
Balance Sheet
Mar 2026Sep 2025Mar 2025Sep 2024Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Equity Capital3333333333
Reserves3262972792772602192001519689
Borrowings123887849343230162827
Other Liabilities94967566593244362623
Total Liabilities545484435396356287277207154142
Fixed Assets16417014389868889646861
CWIP95355061462661200
Investments3949607954392929119
Other Assets2472301831671711331531027573
Total Assets545484435396356287277207154142
Delivery

Delivery Data: NGLFINE

#Date
2505
44%
3602
Value (Cr)Q/T
6
Del
46
Del
4
122-Sep2859
5
6563
221-Sep2732
1
4500
318-Sep2768
3
9782
417-Sep2715
1
4571
516-Sep2674
3
4512
615-Sep2582
2
5591
711-Sep2657
2
6591
810-Sep2726
1
5641
99-Sep2758
1
3480
108-Sep2812
3
5461
117-Sep2873
2
5491
124-Sep2908
2
5431
133-Sep2941
20
7173
142-Sep2689
3
5471
151-Sep2658
2
5491
1631-Aug2650
5
5643
1728-Aug2813
2
4581
1827-Aug2901
1
3431
1926-Aug2877
1
4520
2025-Aug2804
2
5591
2124-Aug2864
4
4552
2221-Aug2948
2
4551
2320-Aug3033
2
5421
2419-Aug3040
6
6272
2518-Aug3024
35
6135
2617-Aug2908
18
6438
2714-Aug3454
1
3491
2813-Aug3436
5
5442
2912-Aug3409
4
5592
3011-Aug3448
2
4531
3110-Aug3458
3
4491
327-Aug3404
2
3421
336-Aug3428
5
4533
345-Aug3428
2
4591
354-Aug3258
1
3611
363-Aug3293
6
5493
3731-Jul3260
1
4570
3830-Jul3280
1
4561
3929-Jul3252
2
5621
4028-Jul3212
2
6651
4127-Jul3226
2
5531
4224-Jul3206
1
3450
4323-Jul3198
2
4521
4422-Jul3256
2
4521
4521-Jul3237
5
4442
4620-Jul3010
3
5662
4717-Jul3132
2
3421
4816-Jul3087
1
4510
4915-Jul3166
1
3531
Daily Market Cap
DateTotal Market CapChangeChg %
22-Sep1,753c107c6.47
17-Sep1,647c50c2.93
10-Sep1,697c61c3.48
07-Sep1,758c71c3.89
04-Sep1,829c40c2.26
03-Sep1,789c133c8.01
01-Sep1,656c18c1.10
31-Aug1,674c96c5.41
27-Aug1,770c3c0.17
26-Aug1,773c43c2.50
25-Aug1,730c49c2.73
24-Aug1,778c90c4.80
21-Aug1,868c7c0.39
19-Aug1,875c12c0.64
18-Aug1,887c95c5.31
17-Aug1,792c360c16.73
14-Aug2,152c10c0.47
13-Aug2,163c47c2.20
12-Aug2,116c28c1.30
11-Aug2,144c00
Stock Checklist
Price is above from 52 week high low average: 67%
Stock is trading above all short term SMAs: YES
Stock is trading above all long term SMAs: YES
Stock is Consistently Improving Long Term: NO
FII purchased in last quarter: YES
Promoters are buying the stock: NO
Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder
Bulk Deals
Events
News
Exchange Filings
Annual Reports
Ratings & Research Reports
Concalls
Announcements
0